These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Clinical Profile of Hyper-IgE Syndrome in India. Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S Front Immunol; 2021; 12():626593. PubMed ID: 33717144 [No Abstract] [Full Text] [Related]
28. Human defects in STAT3 promote oral mucosal fungal and bacterial dysbiosis. Abusleme L; Diaz PI; Freeman AF; Greenwell-Wild T; Brenchley L; Desai JV; Ng WI; Holland SM; Lionakis MS; Segre JA; Kong HH; Moutsopoulos NM JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185668 [TBL] [Abstract][Full Text] [Related]
29. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children. Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211 [TBL] [Abstract][Full Text] [Related]
30. Somatic mosaicism in B cells of a patient with autosomal dominant hyper IgE syndrome. Alcántara-Montiel JC; Staines-Boone T; López-Herrera G; Berrón-Ruiz L; Borrego-Montoya CR; Santos-Argumedo L Eur J Immunol; 2016 Oct; 46(10):2438-2443. PubMed ID: 27488252 [TBL] [Abstract][Full Text] [Related]
31. Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism. Hsu AP; Sowerwine KJ; Lawrence MG; Davis J; Henderson CJ; Zarember KA; Garofalo M; Gallin JI; Kuhns DB; Heller T; Milner JD; Puck JM; Freeman AF; Holland SM J Allergy Clin Immunol; 2013 Jun; 131(6):1586-93. PubMed ID: 23623265 [TBL] [Abstract][Full Text] [Related]
32. Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience. Shamriz O; Rubin L; Simon AJ; Lev A; Barel O; Somech R; Korem M; Matza Porges S; Freund T; Hagin D; Garty BZ; Nahum A; Molho Pessach V; Tal Y Front Immunol; 2022; 13():1044933. PubMed ID: 36605204 [TBL] [Abstract][Full Text] [Related]
33. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255 [TBL] [Abstract][Full Text] [Related]
34. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Minegishi Y; Saito M; Tsuchiya S; Tsuge I; Takada H; Hara T; Kawamura N; Ariga T; Pasic S; Stojkovic O; Metin A; Karasuyama H Nature; 2007 Aug; 448(7157):1058-62. PubMed ID: 17676033 [TBL] [Abstract][Full Text] [Related]
35. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Bittner TC; Pannicke U; Renner ED; Notheis G; Hoffmann F; Belohradsky BH; Wintergerst U; Hauser M; Klein B; Schwarz K; Schmid I; Albert MH Klin Padiatr; 2010 Nov; 222(6):351-5. PubMed ID: 21058221 [TBL] [Abstract][Full Text] [Related]
36. A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3. Steward-Tharp SM; Laurence A; Kanno Y; Kotlyar A; Villarino AV; Sciume G; Kuchen S; Resch W; Wohlfert EA; Jiang K; Hirahara K; Vahedi G; Sun HW; Feigenbaum L; Milner JD; Holland SM; Casellas R; Powrie F; O'Shea JJ Blood; 2014 May; 123(19):2978-87. PubMed ID: 24632714 [TBL] [Abstract][Full Text] [Related]
37. Generation of human induced pluripotent stem cell lines (NIHTVBi011-A, NIHTVBi012-A, NIHTVBi013-A) from autosomal dominant Hyper IgE syndrome (AD-HIES) patients carrying STAT3 mutation. Jin H; Yu Z; Navarengom K; Liu Y; Dmitrieva N; Hsu AP; Schwartzbeck R; Cudrici C; Ferrante EA; Yang D; Holland SM; Freeman AF; Boehm M; Chen G Stem Cell Res; 2019 Dec; 41():101586. PubMed ID: 31707214 [TBL] [Abstract][Full Text] [Related]
38. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. Saito M; Nagasawa M; Takada H; Hara T; Tsuchiya S; Agematsu K; Yamada M; Kawamura N; Ariga T; Tsuge I; Nonoyama S; Karasuyama H; Minegishi Y J Exp Med; 2011 Feb; 208(2):235-49. PubMed ID: 21300911 [TBL] [Abstract][Full Text] [Related]